Your browser doesn't support javascript.
loading
Comparison of the Xpert Flu/RSV XC and Xpress Flu/RSV Assays.
Popowitch, Elena B; Miller, Melissa B.
Affiliation
  • Popowitch EB; McLendon Clinical Laboratories, UNC Health Care, Chapel Hill, North Carolina, USA.
  • Miller MB; Department of Pathology and Laboratory Medicine, UNC School of Medicine, Chapel Hill, North Carolina, USA melissa.miller@unchealth.unc.edu.
J Clin Microbiol ; 56(8)2018 08.
Article in En | MEDLINE | ID: mdl-29769281
Molecular diagnostics for influenza and respiratory syncytial virus (RSV) have become commonplace, and various tests and systems have been cleared by the FDA for use in the United States. We performed a retrospective study to compare the Cepheid Xpress Flu/RSV assay with the Xpert Flu/RSV XC assay, using laboratory-developed tests (LDTs) as the reference method. The Xpress assay was 100% accurate compared to LDTs, whereas the Xpert Flu/RSV XC assay was 96.0% accurate. The Xpress test was determined to be faster and more sensitive than the XC assay.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Influenza A virus / Influenza B virus / Respiratory Tract Infections / Respiratory Syncytial Virus, Human / Molecular Diagnostic Techniques Type of study: Diagnostic_studies / Observational_studies Limits: Humans Language: En Journal: J Clin Microbiol Year: 2018 Document type: Article Affiliation country: United States Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Influenza A virus / Influenza B virus / Respiratory Tract Infections / Respiratory Syncytial Virus, Human / Molecular Diagnostic Techniques Type of study: Diagnostic_studies / Observational_studies Limits: Humans Language: En Journal: J Clin Microbiol Year: 2018 Document type: Article Affiliation country: United States Country of publication: United States